TheJakartaPost
Please Update your browser
Your browser is out of date, and may not be compatible with our website. A list of the most popular web browsers can be found below.
Just click on the icons to get to the download page.
Australia unlikely to open border in 2021: health official
Health department secretary Brendan Murphy, a key adviser in Australia's virus response, said free-flowing travel to and from the country was not expected to resume in 2021.
Change text size
Gift Premium Articles
to Anyone
Share the best of The Jakarta Post with friends, family, or colleagues. As a subscriber, you can gift 3 to 5 articles each month that anyone can read—no subscription needed!
A cricket fan wearing personal protective equipment goes through security at the Sydney Cricket Ground for the first day of the third test between India and Australia, with reduced fan attendance to curb the spread of the coronavirus disease (COVID-19), in Sydney, Australia, January 7, 2021. (REUTERS/Loren Elliott)
A
ustralia's international borders are unlikely to open to travellers this year despite the rollout of coronavirus vaccines, a top health official said Monday.
Health department secretary Brendan Murphy, a key adviser in Australia's virus response, said free-flowing travel to and from the country was not expected to resume in 2021.
"I think that we'll go most of this year with still substantial border restrictions," he told public broadcaster ABC.
"Even if we have a lot of the population vaccinated, we don't know whether that will prevent transmission of the virus.
"And it's likely that quarantine will continue for some time."
Australia's border has been largely closed to overseas visitors since March 2020 to stem the spread of Covid-19, with a limited number of citizens and their families allowed to return each week.
Tens of thousands of Australians remain stranded overseas as a result, while returning travellers must pay about Aus$3,000 ($2,300) to quarantine inside a hotel room for 14 days.
The country has secured access to both the Pfizer and Oxford/AstraZeneca vaccines, with the rollout scheduled to begin in late February but still awaiting approval from medical regulators.
